Gloshell
Ingredients

Ingredient Dictionary

SOLVENT BLUE 35

Molecular structure

Cosmetic roles

Dyes hairHAIR DYEING

Safety & regulatory references

Banned
Argentina · ASEAN · Brazil · Canada · China · European Union · South Korea · United Kingdom

Source: ASEAN Cosmetic Directive · EU Cosmetics Regulation · Health Canada Cosmetic Ingredient Hotlist · MFDS (Korea) cosmetic regulatory information · UK cosmetics regulations (OPSS)

Health Canada Cosmetic Ingredient Hotlist · prohibited in cosmetics

Source: Health Canada Cosmetic Ingredient Hotlist

Restriction II/389

Source: EU CosIng ingredient list

More data — names, identifiers, properties, test records, literature

Names & identifiers

SOLVENT BLUE 35INCI솔벤트청색35호Korean label name (MFDS standard)
CAS No.chemical registry number
12769-17-4
CAS No.chemical registry number
12769-17-4 / 17354-14-2
CAS No.chemical registry number
17354-14-2
EC No.EU chemical inventory number
241-379-4
DTXSIDUS EPA chemical ID
DTXSID5044605
DTXCIDUS EPA compound ID
DTXCID3024605
IUPAC
1,4-Bis(butylamino)anthracene-9,10-dione
Molecular formula
C22H26N2O2
Molecular weight
350.462 g/mol

Measured properties

Appearance
Dry Powder

Values measured on the substance itself, not a specification for a commercial raw material.

Source: PubChem

What products actually use it for

What the 7 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.

  • Dye6
  • Fragrance1

Source: US EPA CompTox dashboard

Irritation and sensitisation studies

2 skin studies and 1 eye studies are on record.

Classed as low2

The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 3 studies
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
  • Not likely to be sensitizing
    skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to

Source: US EPA CompTox dashboard

Related literature

Linked databases 17